Want to take quizzes and track your credits?
What is the incidence of first transient ischemic attack (TIA) and how is TIA associated with subsequent stroke risk?
In this population-based cohort study from 1948-2017, the estimated crude TIA incidence was 1.19/1000 person-years, the risk of stroke was significantly greater after TIA compared with matched control participants who did not have a TIA (adjusted hazard ratio, 4.37), and the risk of stroke within 90 days after TIA was significantly lower in the most recent epoch from 2000-2017 compared with an earlier period from 1948-1985 (hazard ratio, 0.32).
Among participants in the Framingham Heart Study from 1948-2017, TIA was associated with greater risk of subsequent stroke compared with matched control participants without TIA, and the risk of stroke after a TIA was lower in more recent periods.
Accurate estimation of the association between transient ischemic attack (TIA) and risk of subsequent stroke can help to improve preventive efforts and limit the burden of stroke in the population.
To determine population-based incidence of TIA and the timing and long-term trends of stroke risk after TIA.
Design, Setting, and Participants
Retrospective cohort study (Framingham Heart Study) of prospectively collected data of 14 059 participants with no history of TIA or stroke at baseline, followed up from 1948-December 31, 2017. A sample of TIA-free participants was matched to participants with first incident TIA on age and sex (ratio, 5:1).
Calendar time (TIA incidence calculation, time-trends analyses), TIA (matched longitudinal cohort).
Main Outcomes and Measures
The main outcomes were TIA incidence rates; proportion of stroke occurring after TIA in the short term (7, 30, and 90 days) vs the long term (>1-10 years); stroke after TIA vs stroke among matched control participants without TIA; and time trends of stroke risk at 90 days after TIA assessed in 3 epochs: 1954-1985, 1986-1999, and 2000-2017.
Among 14 059 participants during 66 years of follow-up (366 209 person-years), 435 experienced TIA (229 women; mean age, 73.47 [SD, 11.48] years and 206 men; mean age, 70.10 [SD, 10.64] years) and were matched to 2175 control participants without TIA. The estimated incidence rate of TIA was 1.19/1000 person-years. Over a median of 8.86 years of follow-up after TIA, 130 participants (29.5%) had a stroke; 28 strokes (21.5%) occurred within 7 days, 40 (30.8%) occurred within 30 days, 51 (39.2%) occurred within 90 days, and 63 (48.5%) occurred more than 1 year after the index TIA; median time to stroke was 1.64 (interquartile range, 0.07-6.6) years. The age- and sex-adjusted cumulative 10-year hazard of incident stroke for patients with TIA (130 strokes among 435 cases) was 0.46 (95% CI, 0.39-0.55) and for matched control participants without TIA (165 strokes among 2175) was 0.09 (95% CI, 0.08-0.11); fully adjusted hazard ratio [HR], 4.37 (95% CI, 3.30-5.71; P < .001). Compared with the 90-day stroke risk after TIA in 1948-1985 (16.7%; 26 strokes among 155 patients with TIA), the risk between 1986-1999 was 11.1% (18 strokes among 162 patients) and between 2000-2017 was 5.9% (7 strokes among 118 patients). Compared with the first epoch, the HR for 90-day risk of stroke in the second epoch was 0.60 (95% CI, 0.33-1.12) and in the third epoch was 0.32 (95% CI, 0.14-0.75) (P = .005 for trend).
Conclusions and Relevance
In this population-based cohort study from 1948-2017, the estimated crude TIA incidence was 1.19/1000 person-years, the risk of stroke was significantly greater after TIA compared with matched control participants who did not have TIA, and the risk of stroke after TIA was significantly lower in the most recent epoch from 2000-2017 compared with an earlier period from 1948-1985.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Vasileios-Arsenios Lioutas, MD, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215 (email@example.com).
Accepted for Publication: December 3, 2020.
Author Contributions: Dr Himali had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs Lioutas, Ivan, Beiser, and Seshadri contributed equally.
Concept and design: Lioutas, Ivan, Romero, Beiser, Seshadri.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Lioutas, Ivan, Seshadri.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Lioutas, Himali, Beiser.
Obtained funding: Seshadri.
Administrative, technical, or material support: Aparicio, Leveille, Romero.
Supervision: Romero, Beiser, Seshadri.
Conflict of Interest Disclosures: Dr Lioutas reported receiving personal fees from Qmetis and serving as the Continuing Medical Education editor for Stroke (American Heart Association). No other disclosures were reported.
Funding/Support: This study was supported by grants from the National Institute on Aging (R01 AG054076, R01 AG049607, R01 AG033040, R01 AG063507, R01 AG059725, RF1 AG052409, RF1 AG061872, U01 AG049505, AG058589), grants from the National Institute of Neurological Disorders and Stroke (NS017950 and UH2 NS100605), and the National Heart, Blood, and Lung Institute contract for the Framingham Heart Study (N01-HC-25195, HHSN268201500001I, and 75N92019D00031).
Role of the Funder/Sponsor: The National Institutes of Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
You currently have no searches saved.